Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
35 participants
INTERVENTIONAL
2013-07-31
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Equivalent Glycemic Load and Insulinemic Response Elicited by 7 Low Carbohydrate Products in Healthy Adults
NCT05870891
Effect of Fiber Composite-enriched Breads on Glycemic Responses
NCT03224806
Post-prandial Glycemic Response to Fiber in Healthy Adults
NCT03252704
Glycaemic Index of Fibre-rich Flours in Healthy Volunteers
NCT05372666
A Study to Investigate the Effect of SFF on Glucose and Insulin Responses
NCT05587426
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This research is important to determine the feasibility of developing fibre enriched carbohydrate foods that maintains the original organoleptic properties and is effective in reducing postprandial blood glucose response.
35 subjects will be recruited in phase I to complete a sensory evaluation on the test foods. Following tasting of the control and fibre-enriched samples, data on each subjects' liking or disliking will be collected through a 9-point hedonic scale.
An acute crossover RCT will be conducted in phase II by 10 healthy individuals. Subjects will be randomized to consume one the treatments at each visit and blood glucose levels over 120min and satiety scores will be measured.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PGX
samples of white bread, mashed potatoes, muffin, hot breakfast cereal with the addition of soluble fibre blend
Bread
Samples of white bread, with or without the addition of PGX fibre blend
Mashed Potatoes
samples of mashed potatoes, with or without the addition of soluble fibre blend
Muffins
Samples of muffins, with or without the addition of PGX fibre blend
Hot Breakfast Cereal
Samples of hot breakfast cereal without the addition of soluble fibre blend
Control
samples of white bread, mashed potatoes, muffin, hot breakfast cereal without the addition of soluble fibre blend
Bread
Samples of white bread, with or without the addition of PGX fibre blend
Mashed Potatoes
samples of mashed potatoes, with or without the addition of soluble fibre blend
Muffins
Samples of muffins, with or without the addition of PGX fibre blend
Hot Breakfast Cereal
Samples of hot breakfast cereal without the addition of soluble fibre blend
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bread
Samples of white bread, with or without the addition of PGX fibre blend
Mashed Potatoes
samples of mashed potatoes, with or without the addition of soluble fibre blend
Muffins
Samples of muffins, with or without the addition of PGX fibre blend
Hot Breakfast Cereal
Samples of hot breakfast cereal without the addition of soluble fibre blend
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 18.5 - 25 kg/m2
* Post-menopausal or not pregnant women
Exclusion Criteria
* Swallowing difficulties
* Chronic use of medications or fibre
* GI conditions affecting stomach pH
* Must not be enrolled in another study
* History of liver or kidney disease, diabetes, hypertension, stroke or myocardial infarctions, thyroid disease, celiac /gastrointestinal disease, HIV positive or AIDS
19 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unity Health Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vladimir Vuksan
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vladimir Vuksan, PhD
Role: PRINCIPAL_INVESTIGATOR
St. Michael's & University of Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Michael's
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-379C
Identifier Type: OTHER
Identifier Source: secondary_id
White Line
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.